The enkephalin analog, H-Tyr-~-Thr-Gly-Phe-A~Pro-NH~ X HCI (V1)( [ D-Thr' , A3Pro5 ] -enkephalinamide), has been synthesized by conventional methods in solution and purified t o homogeneity by reversed phase HPLC. The analog is a potent analgesic agent. F o r evaluation of some of its biological activity a related compound [ D-Thr', ThzS]-enkephalinamide (XI) was also synthesized in solution. Anti-diarrhea activity was evaluated in mice by the intravenous route for anti-DL-5-hydroxytryptophan (5-HTP) induced diarrhea activity. Analgesic activity was assayed by the method of Nilsen in mice using the intravenous route, and by a modified tail flick test in rats and the acetic acid writhing test in mice following subcutaneous administration. Within the constraints of the assays the two analogs are approximately equipotent. Both are less active than [D-Ala' , MePhe4, Met(O)ol] -enkephalinol (XII). Earlier receptor binding studies of compound XI indicated enhanced affinity for the p receptor and little for the 6 receptor. By comparison this may also be the case for compound VI.